Bovine fasciculata adrenal cells contain specific high-affinity (KD 2.3 ± 0.4 X 10-10 M) and low-capacity (1910 ± Corticotropin (ACTH) is the main hormone in mammals that regulates glucocorticoid secretion. However, detection and characterization of physiologically relevant ACTH receptors have been difficult (for review, see ref. 1), because of the low biological activity of the labeled ACTH, which was probably related to the introduction of a bulky iodine atom into Tyr-2 (2) and to the oxidation of Met-4 (3). These difficulties were overcome by synthesizing an analog of ACTH in which Tyr-2 was replaced by Phe and Met-4 was replaced by norleucine (4, 5) or by using '25I-labeled ACTH labeled only on Tyr-23 (6). Using these labeled hormones, physiologically relevant ACTH receptors have been characterized in rat (5, 7), human (8), and domestic fowl (6) adrenal cells. However, the regulation of adrenal-cell ACTH receptors has only been investigated once in vivo (9) and twice in vitro (10, 11) and the results are contradictory. The first study (9) indicated that ACTH has a positive effect on its own receptors, whereas the results of the in vitro studies suggest the absence of such an effect (10, 11 Cell Culture and Binding Studies. Bovine adrenocortical fasciculata cells were prepared and cultured in a serum-free medium (12, 13). On the second day of culture the medium was removed and replaced with fresh medium alone or with the factors indicated. At the end of this experimental period, the medium was removed, and the cells were washed twice with ice-cold 0.9% NaCl, once with ice-cold acidic glycine buffer (50 mM glycine/100 mM NaCl, pH 3) for 4.5 min at 4°C, and twice with 0.9% NaCl, to remove the membranebound ligands (12) . Then the cells were incubated for 1 hr at 20°C with 0.1 pmol of 125I-ACTH in F-12/DMEM containing 0.5% bovine serum albumin and 0.1% bacitracin. At the end of the incubation, the medium was removed and the cells were washed three times with 0.9% NaCl and then dissolved in 0.5 M NaOH/0.4% sodium deoxycholate. The radioactivity was measured in a y counter with 75% efficiency. All the binding assays were performed in triplicate. Specific binding was determined by subtracting from the total binding the radioactivity associated with cells in the presence of 10-6 nonradioactive ACTH. This nonspecific binding accounted for at most 10% of the total binding. On molar basis, ACTH-(1-39) and ACTH-(1-24) were equipotent to displace bound 125I-ACTH and to stimulate cAMP and steroid production.
enhanced the steroidogenic responsiveness to further hormonal stimulation. However, at higher concentrations the hormone induced an apparent steroidogenic desensitization that was probably related to a depletion of endogenous cholesterol, since cortisol production in the presence of 22-(R)-hydroxycholesterol was increased. Neither angiotensin-il nor atrial natriuretic factor alone modified ACTH receptors, but angiotensin-II partially blocked the stimulatory effect of ACTH. Thus, ACTH is one of the few polypeptide hormones having a positive trophic effect on its own receptors and target-cell responsiveness.
Corticotropin (ACTH) is the main hormone in mammals that regulates glucocorticoid secretion. However, detection and characterization of physiologically relevant ACTH receptors have been difficult (for review, see ref. 1) , because of the low biological activity of the labeled ACTH, which was probably related to the introduction of a bulky iodine atom into Tyr-2 (2) and to the oxidation of Met-4 (3). These difficulties were overcome by synthesizing an analog of ACTH in which Tyr-2 was replaced by Phe and Met-4 was replaced by norleucine (4, 5) or by using '25I-labeled ACTH labeled only on Tyr-23 (6) . Using these labeled hormones, physiologically relevant ACTH receptors have been characterized in rat (5, 7), human (8) , and domestic fowl (6) adrenal cells. However, the regulation of adrenal-cell ACTH receptors has only been investigated once in vivo (9) and twice in vitro (10, 11) and the results are contradictory. The first study (9) indicated that ACTH has a positive effect on its own receptors, whereas the results of the in vitro studies suggest the absence of such an effect (10, 11 Cell Culture and Binding Studies. Bovine adrenocortical fasciculata cells were prepared and cultured in a serum-free medium (12, 13) . On the second day of culture the medium was removed and replaced with fresh medium alone or with the factors indicated. At the end of this experimental period, the medium was removed, and the cells were washed twice with ice-cold 0.9% NaCl, once with ice-cold acidic glycine buffer (50 mM glycine/100 mM NaCl, pH 3) for 4.5 min at 4°C, and twice with 0.9% NaCl, to remove the membranebound ligands (12) . Then the cells were incubated for 1 hr at 20°C with 0.1 pmol of 125I-ACTH in F-12/DMEM containing 0.5% bovine serum albumin and 0.1% bacitracin. At the end of the incubation, the medium was removed and the cells were washed three times with 0.9% NaCl and then dissolved in 0.5 M NaOH/0.4% sodium deoxycholate. The radioactivity was measured in a y counter with 75% efficiency. All the binding assays were performed in triplicate. Specific binding was determined by subtracting from the total binding the radioactivity associated with cells in the presence of 10-6 nonradioactive ACTH. This nonspecific binding accounted for at most 10% of the total binding. On molar basis, ACTH-(1-39) and ACTH-(1-24) were equipotent to displace bound 125I-ACTH and to stimulate cAMP and steroid production.
Other Methods. To test the functional activity of the adrenal cells, at the end of each experimental protocol, the cells were washed as described above and incubated in fresh medium alone or with effectors. One aliquot of the medium was taken after 1 hr for cAMP determination and another was taken after 2 hr for steroids; both were frozen until assay by a specific radioimmunoassay (12) . Statistical analysis was performed with Student's t test for comparison oftwo groups. Differences were considered significant when P < 0.05.
RESULTS
Cultured bovine adrenal cells specifically bind 125I-ACTH (Fig. 1) . The Scatchard analysis of the binding data revealed two binding sites: one of high affinity (KD = 2.3 + 0.4 X 10-1o M, n = 4) and low capacity (1910 + 300 sites per cell, n = 4); the second of low affinity (KD = 1.6 6 0.6 X 10-7 M) and high capacity (32,000 to 90,000 sites per cell). In bovine adrenal 
4978
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (8), the concentrations of ACTH causing half-maximal cAMP and steroid production were significantly lower (ED50 6 ± 1 x 10-12 and 5 ± 0.6 x 10-13, respectively; n = 3) than those causing half-maximal inhibition of the binding.
The binding of ACTH to cultured bovine adrenal cells was lower on day 1 than on day 2 and this might be related to an incomplete recovery of membrane-bound receptors after cell isolation by enzymatic digestion, but, thereafter, it remained fairly constant for at least 2 days. In contrast, treatment with ACTH produced a 3-fold increase in ACTH binding with the maximal effects within 48 hr (Fig. 2) . Therefore, all the following experiments were started on day 2 of the culture and continued for two additional days. The stimulatory effects of ACTH on its own receptors were dose-dependent with an ED50 10-11 M and a Vane 10-10 M (Fig. 3) .
However, 10-8 M ACTH produced a small but significant decrease of its own receptors when compared to the effects of 101 M. ± 66 Adrenal cells were pretreated with the indicated effector for 48 hr. Then the medium was removed, the cells were washed with acidic glycine buffer and incubated in the absence (control) or in the presence of ACTH (10-9 M) or (22R)-hydroxycholesterol (5 x 10-5 M). cAMP and cortisol were measured in the medium after 1 hr and 2 hr, respectively. The results are the mean ± SD of quadruplicate determinations.
buffer removed more than 98% of the bound hormone and since the same phenomenon was observed when the cells were treated with high concentrations of 8-bromoadenosine 3',5'-cyclic monophosphate (8Br-cAMP). After a 48-hr treatment with this nucleotide at 5 x 10-5, 10-4, 5 X l0-4, 10-3, or 2 x 10-3 M, the percents of ACTH receptors compared to control cells were 250, 325, 390, 310, and 180%, respectively. The stimulatory effects of ACTH on its own receptors were due to an increase in the number of sites per cell [from 1910 ± 300 to 8650 ± 900 sites per cell (n = 3)] of the high-affinity binding site without modification of their affinity (Fig. 3) . It must be pointed out that pretreatment with ACTH had no effect on the binding affinity or on the receptor number of the low-affinity binding site.
Pretreatment of adrenal cells with increasing concentrations of ACTH enhanced both the cAMP and the cortisol response to further hormonal stimulation (Fig. 3) . The maximal cAMP responsiveness was observed after pretreatment with 10-10 to 10-9 M ACTH. Again, pretreatment with 10-8 M ACTH significantly reduced the response compared to that observed after pretreatment with 10-M ACTH. Moreover, ACTH pretreatment also enhanced the cAMP response to forskolin, but this increase was less pronounced than the response to ACTH and required higher ACTH concentrations. The increased cAMP response to ACTH of cells pretreated with 10-9 M ACTH was due to an increase of the maximal velocity (Fig. 4) . However, this change in the Vm.. desensitization when compared to the effects of 10-11 M ACTH. This steroidogenic desensitization, which was also induced by a high concentration of 8Br-cAMP (10-3 M) ( Table 1 ) was most likely related to a depletion, by the pretreatment, of the endogenous pool of cholesterol, since the cortisol production in the presence of (22R)-hydroxycholesterol by cells pretreated with 10-8 M ACTH or 10-3 M 8Br-cAMP was similar to that produced by cells pretreated with a lower concentration of both effectors, but higher than that of control cells (Table 1) .
In contrast to the positive trophic effect of ACTH and 8Br-cAMP on adrenal cell ACTH receptors and adenylate cyclase responsiveness, two other effectors of adrenal cells, A-II and ANF alone, had no effects, but A-II inhibited the stimulatory action of ACTH and 8Br-cAMP on ACTH receptors by 50%o and the stimulatory effect of ACTH on adenylate cyclase responsiveness by 50% (Table 2) . Cycloheximide, at concentrations that inhibited more than 90% protein synthesis by adrenal cells, reduced by 50o the ACTH receptors within 48 hr and the antibiotic completely blocked the stimulatory action on this parameter of both ACTH and 8Br-cAMP on ACTH receptors and responsiveness (Table 2) .
DISCUSSION
The present studies show that 125I-labeled human [Tyr23]-ACTH binds specifically to cultured bovine fasciculata cells. The binding affinity and the number of receptors of the first binding site agree with the values reported in rat (5, 14) , human (8) , and domestic fowl (6) adrenal cells. A second site of low affinity and high capacity has also been reported by some authors (6, 7) but not by others (5, 8) . The significance of this second site in our model is unknown since it cannot be related to any physiological responses of adrenal cells. Ramachandran and co-workers (1, 5, 8) have suggested that this second site could be the result of using inappropriately labeled ACTH. The radiolabeled ACTH we used was monoiodinated at Tyr-23 and retained more than 90% of the biological activity of unlabeled ACTH but had some contaminates (<5%), "WI-labeled [Tyr2]ACTH and an analog with an oxidized Met-4 (not a product ofAmersham). Thus, this small contamination that varies from one batch to another could explain the scatter in the number of the low-affinity binding sites that we observed.
In contrast with the loss of receptors and desensitization of target cells induced by many hormones (15) , our results clearly show that pretreatment of adrenal cells with physiological concentrations of ACTH enhanced in a timedependent manner both the number of its own receptors and the cAMP response to further hormonal stimulation, indicating that most of the new receptors were coupled to the adenylate cyclase. These trophic effects of ACTH, which were mimicked by low concentrations of exogenous cAMP, were partially reversed by high concentrations of either 10-8 M ACTH or 10-3 M 8Br-cAMP. Interestingly, at high con- centrations, ACTH also enhanced the acute cAMP response to forskolin. Thus the above results indicate that the positive effects of ACTH on the response of adenylate cyclase to its own stimulation is due mainly to an increase of ACTH receptors and less to an increased activity of the catalytic subunit of the adenylate cyclase.
Short-term treatment (4-6 hr) with 10-9 M ACTH of cultured (11) or of superfused (16) rat adrenal cells was able to desensitize the cAMP response to further hormonal stimulation, and in one study the desensitization was associated with a small (<15%) decrease of ACTH receptors. The discrepancy between our results and those of the previous work could be due to a species difference, but most likely it is due to a difference in the experimental protocol. Indeed, we observed that within the first 12 hr of ACTH treatment, both the number of ACTH receptors and the cAMP response (data not shown) to further ACTH stimulation were slightly decreased, whereas at 24 hr both parameters were significantly higher than in control cells. Thus, our in vitro findings agree with those obtained in vivo, showing that within 24 hr endogenous and exogenous ACTH enhance its own receptors (9, 17) .
Several groups have shown that treatment of normal or tumoral adrenal cells with high concentrations of ACTH caused steroidogenic refractoriness (10, 11, 16) . Our results clearly show that this desensitization is only observed at high concentrations of the hormone and is due mainly to the depletion of endogenous cholesterol during the pretreatment period.
In contrast with the above positive effects of ACTH on bovine fasciculata adrenal cells, in the same cells, A-II caused down regulation of its own receptors and homologous and heterologous desensitization (12) . Thus, the effects of ACTH appear to be very specific on this target cell.
Many in vivo studies have shown that in humans repeated (18) or long-term (19) treatment with ACTH enhances the glucocorticoid secretion. Similarly, in Cushing disease and in the ectopic ACTH syndrome the glucocorticoid secretion is increased (20) . Our results suggest that the enhanced ACTH responsiveness observed in all these situations is not only due to the positive trophic effect of ACTH on the expression of the genes encoding several enzymes involved in the steroidogenic pathway (21) but also to the positive effect of the hormone on its own receptors and on the response of the adenylate cyclase to its own stimulation.
